Skills this job asks for
TranslationCommunicationLeadership
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Mar 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Mar 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
About Stoke:
Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/
Position Purpose:
The VP/SVP, Genomics & Data Science , will serve as a key scientific and strategic leader responsible for integrated Computational, Genomics, and Data systems, Therapeutic Design, and essential support of Discovery, Translational Development, and Technology Innovation. This leader will also oversee the establishment and stewardship of cohesive scientific computation, molecular & genomic data generation, and high-dimensional data interpretation and representation across the R&D organization. Reporting to the Chief Scientific Officer, this executive will grow a high-impact, multi-disciplinary team advancing therapeutic understanding, and partner across the organization to drive therapeutic development and translation, as well as pursue novel and differentiated technologies and scientific opportunities. The ideal candidate will possess exceptional communication skills, and a proven ability to operate effectively within a complex matrix organization.
Key Responsibilities:
• Provide strategic and technical leadership across scientific computation, molecular & genomic functions, and therapeutic design, including organizational management and cross-functional engagement
• Mentor and grow high-performing, technical and scientific team, with an enterprise perspective to data generation and interpretation, collaboration, and efficient execution on priorities
• Champion and oversee scientific computation/AI innovation, including multi-dimensional analytics, data representation & visualization, target insights, integration of genetics and internal/external data, and fit-for-purpose systems
• Lead therapeutic design, including exploration of next-generation approaches
• Establish and drive targeted genomics and molecular assays, including high-throughput approaches, model systems, and biomarker strategies to support development programs at all stages
• Proactively identify external opportunities and collaborations to augment core capabilities
• Champion and represent computational and molecular technologies and capabilities to key internal and external stakeholders, including senior management, board and SAB, through presentation, and publication.
Required Skills & Experience:
• Minimum 12 years of progressing experience leading quantitatively focused and multidisciplinary teams in the pharmaceutical, biotechnology, or life sciences industry
• Proven track record building and leading high-performing integrated teams, developing talent, and balancing enterprise priorities across efficiency, risk, and innovation
• Extensive experience in computational sciences, bioinformatics, genomic technologies, and related fields – ideally in the context of genetic medicines and therapeutic development
• Ph.D. or equivalent in Computer Science, Genomics, Molecular B
Apply on employer site ↗